0001062993-15-003576.txt : 20150625
0001062993-15-003576.hdr.sgml : 20150625
20150625170252
ACCESSION NUMBER: 0001062993-15-003576
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150623
FILED AS OF DATE: 20150625
DATE AS OF CHANGE: 20150625
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOSPECIFICS TECHNOLOGIES CORP
CENTRAL INDEX KEY: 0000875622
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 113054851
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 35 WILBUR ST
CITY: LYNBROOK
STATE: NY
ZIP: 11563
BUSINESS PHONE: 5165937000
MAIL ADDRESS:
STREET 1: 35 WILBUR STREET
CITY: LYNBROOK
STATE: NY
ZIP: 11563
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Gitman Paul
CENTRAL INDEX KEY: 0001375378
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34236
FILM NUMBER: 15952381
MAIL ADDRESS:
STREET 1: 167 EXECUTIVE DRIVE
CITY: MANHASSET HILLS
STATE: NY
ZIP: 11040
4
1
form4.xml
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
X0306
4
2015-06-23
0000875622
BIOSPECIFICS TECHNOLOGIES CORP
BSTC
0001375378
Gitman Paul
C/O BIOSPECIFICS TECHNOLOGIES CORP.
35 WILBUR STREET
LYNBROOK
NY
11563
1
0
0
0
Common Stock, $0.001 par value
2015-06-23
4
M
0
6308
13.60
A
58133
D
Common Stock, $0.001 par value
2015-06-23
4
M
0
15000
26.43
A
73133
D
Common Stock, $0.001 par value
2015-06-23
4
M
0
15000
20
A
88133
D
Common Stock, $0.001 par value
2015-06-23
4
S
0
6308
53.5856
D
81825
D
Common Stock, $0.001 par value
2015-06-23
4
S
0
15000
51.8390
D
66825
D
Common Stock, $0.001 par value
2015-06-23
4
S
0
15000
50.9540
D
51825
D
Stock Option (Right to Buy)
13.60
2015-06-23
4
M
0
6308
0
D
2018-06-09
Common Stock, $0.001 par value
6308
8692
D
Stock Option (Right to Buy)
26.43
2015-06-23
4
M
0
15000
0
D
2019-09-07
Common Stock, $0.001 par value
15000
0
D
Stock Option (Right to Buy)
20.00
2015-06-23
4
M
0
15000
0
D
2018-09-07
Common Stock, $0.001 par value
15000
0
D
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 8, 2015.
The selling price of $53.5856 is reflective of the weighted average sale price of all transactions reported on this line. The prices for the transactions reported on this line range from $53.00 to $56.04. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
The selling price of $51.8390 is reflective of the weighted average sale price of all transactions reported on this line. The prices for the transactions reported on this line range from $51.00 to $56.04. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
The selling price of $50.9540 is reflective of the weighted average sale price of all transactions reported on this line. The prices for the transactions reported on this line range from $49.00 to $56.04. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
The option was granted on June 10, 2008 and it was to vest monthly with respect to 1/12 of the total number of shares until all shares underlying the option have vested. All shares underlying the option have vested.
The option was granted on September 8, 2009 and it was to vest monthly with respect to 1/12 of the total number of shares until all shares underlying the option have vested. All shares underlying the option have vested.
The option was granted on September 8, 2008 and it was to vest monthly with respect to 1/12 of the total number of shares until all shares underlying the option have vested. All shares underlying the option have vested.
/s/ Carl A. Valenstein, attorney-in-fact for Paul Gitman
2015-06-25